The effect of duration of wound drainage on allogeneic blood transfusions using a postoperative retransfusion system after major orthopaedic surgery.”
Completed
- Conditions
- retransfusion, retransfusiedrainjoint arthroplasty, gewrichtsvervangingduration, tijd
- Registration Number
- NL-OMON26356
- Lead Sponsor
- MC HaaglandenLocatie Antoniushove en WesteindePostbus 4322501 CK Den Haag
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 570
Inclusion Criteria
1. Patients scheduled to undergo elective major orthopaedic surgery (hip, knee);
2. Male and non-pregnant female patients between 18-80 years of age;
Exclusion Criteria
1. Patients with a major surgical procedure during the 12 weeks before the study-related operation;
2. No other used alternatives to reduce allogeneic blood transfusions, such as preoperative epoetin alpha (Eprex®) injections or intra-operative cell saving (Sangvia®);
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Allogeneic blood transfusion rate.
- Secondary Outcome Measures
Name Time Method 1. Haemoglobin level (pre-operative, 24 and 72 hrs after operation);<br /><br>2. Amount of blood collected with Bellovac ABT at 6 hours and 24 hours;<br /><br>3. Complications, especially wound problems;<br /><br>4. Length of hospital stay;<br /><br>5. Co morbidity.